Glyphosate and cancer – revisited

Recently, a jury in San Francisco, California recommended that Monsanto be forced to pay $289 million to a man who has been diagnosed with non-Hodgkin lymphoma. It was a pretty stunning result from a court case that has been watched very closely. I haven’t read the court transcripts, and I don’t know what the jury was told or what was withheld from them. And I have no desire to make accusations that either side was acting in bad faith. So …

Read More

Glyphosate and Cancer: What does the data say?

A little over a week ago, the International Agency for Research on Cancer (IARC) announced that glyphosate would be added to their list of agents that are “probably carcinogenic to humans.” Glyphosate wasn’t the only pesticide added to the list, but as Nathanael Johnson noted at Grist, glyphosate tends to be something of a lightning rod due to its association with genetically engineered (Roundup Ready) crops. Let me start by pointing out I’m pretty late to the party writing about this. The …

Read More

Why I think the Seralini GM feeding trial is bogus

UPDATE: If you’re looking for information on the ‘republished’ version of this manuscript, a full statistical analysis of the released data can be found here. If you’re following the news about the French GM maize feeding trial, you’ve probably heard: (A) we need to pull GMO crops off the market immediately; or (B) that the study is flawed and is basically meaningless. I guess I find myself leaning toward the second group on this one. Here is why I think the …

Read More